Clinical trial
Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral…
NCT00141401 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141401 |
|---|---|
| Title | Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. |
| Official title | An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy, Painful |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 240 |
| Start date | Sep 1, 1999 |
| Completion | Jul 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Aug 17, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: